City
Epaper

IASST’s smart sensor to help Parkinson’s patients to manage drug dosage 

By IANS | Updated: August 27, 2024 17:30 IST

New Delhi, Aug 27 Scientists at the Institute of Advanced Study in Science and Technology (IASST), an autonomous ...

Open in App

New Delhi, Aug 27 Scientists at the Institute of Advanced Study in Science and Technology (IASST), an autonomous institute of the Department of Science and Technology, on Tuesday revealed a low-cost and portable smartphone-based sensor system that can assist in managing symptoms of Parkinson's disease.

People with Parkinson’s face a continuous decrease in neuron cells that reduces the levels of dopamine (neurotransmitter) in their body. L-dopa is a chemical that is converted to dopamine in our body and so acts as an anti-Parkinson’s drug.

A correct dosage of L-dopa ensures the disease remains manageable. When L-dopa decreases, Parkinson's symptoms return. On the other hand, too much of the chemical can cause serious side effects like dyskinesia, gastritis, psychosis, paranoia, and orthostatic hypotension.

IASST’s novel optical sensor system uses a fluorescence turn-on mechanism to instantly detect low levels of L-dopa in biological samples. It also reveals the precise dosage required.

The system acts as an effective probe that “can detect L-dopa in real samples such as blood plasma, sweat, and urine within a linear range of 5 micrometre to 35 micrometre. The corresponding detection limits were determined to be 95.14 nM, 93.81 nM, and 104.04 nM, respectively,” said the researchers, in the paper published in the journal Progress in Neurobiology.

The smartphone-based electronic device comes with an electric circuit connected to a 365nm LED powered by a 5V smartphone charger.

The whole setup is immersed in a dark chamber to isolate it from external light. Visual colour changes during the sensing process were observed by illuminating the sensor probe with the 365 nm LED and capturing images with a smartphone camera.

“The RGB values from the images are used to evaluate L-dopa concentration using a mobile app. This simple, cost-effective, and rapid screening tool is crucial for on-spot analyte detection in remote areas lacking advanced equipment,” the team said.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

CricketPrasidh-Siraj's fiery spells keep India in hunt to win Oval Test against England (Day 4 Lunch)

Other Sports5th Test: How costly might that be, says Ponting on Siraj’s reprieve to Brook

TennisLexington Open 2025 Tennis: India pair Ramkumar Ramanathan, Anirudh Chandrasekar clinch men's doubles title

NationalTrinamool Congress highlights another instance of a Bengali migrant worker's death in Haryana

BusinessSemiconductor mission pushes India from being aspirant to becoming global powerhouse

Health Realted Stories

HealthCentre cuts prices of 35 essential medicines

HealthSpecial edition of 'Fit India-Sundays on Cycle' held at JLN Stadium today

HealthOver 18,900 organ transplants in 2024, highest in a single year: JP Nadda

HealthDiabetic patient can return to normal blood sugar levels without medication: PGI Chandigarh

HealthStates asked to undertake regular screening to tackle rising fatty liver disease: Nadda